Description
+ Include: 27 videos + 25 pdfs, size: GB
+ Target Audience: neuroscientists, neuro-oncologists, clinical researchers
+ Sample video: contact me for sample video
+ Information:
The Advances in Brain Tumor Research & Therapy 2025 is the inaugural Cold Spring Harbor Laboratory meeting dedicated to the cutting edge of brain tumor science. Running from July 17–20, 2025, this event brings together leading researchers and clinicians to catalyze collaboration and accelerate breakthroughs against some of the most devastating neurologic cancers.
What You Will Learn
-
Emerging insights in clinical care, imaging, pathology, surgery, radiation oncology, and therapeutic innovation for brain tumors
-
Foundational and translational knowledge in cancer genetics, pediatric brain tumors, and mechanisms of tumor development and progression
-
Advances in gliomas, meningiomas, medulloblastoma, ependymoma, DIPG, and brain metastases
-
Cutting-edge research in mouse models, genomics, proteogenomics, metabolism, the tumor microenvironment, angiogenesis, immunology, and preclinical drug development
-
Strategies for clinical translation including trial design, overcoming blood-brain barrier challenges, and optimizing therapeutic interventions
Event Details
-
Event: Cold Spring Harbor Laboratory – Advances in Brain Tumor Research & Therapy 2025
-
Dates: July 17–20, 2025 (begins evening of July 17, ends at noon July 20)
-
Highlights: Small-group setting promoting mutual exchange between early-career investigators and established experts; hosted keynotes and diverse speaker lineup from top institutions
Who Should Attend
Neuroscientists, neuro-oncologists, clinical researchers, graduate students, postdocs, and clinicians who focus on brain tumor biology, translating basic science, and advancing therapeutic strategies.
Why Attend
This inaugural meeting offers a rare and powerful opportunity to join a high-powered collective of innovators shaping the future of brain tumor therapy. With its intimate, collaborative setting and expert-led program, attendees will gain cutting-edge insights, spark new partnerships, and leave poised to contribute to meaningful advances in brain tumor research and patient care.
+ Topics:
Clinical Aspects of Brain Tumors
Pathology / Imaging / Population biology / Quality of Life / Surgery / Radiation oncology / Medical therapies
Genetics and Developmental Biology
Cancer Genetics / Pediatric brain tumors / Cancer neuroscience
Gliomas and Nervous System Disorders
Gliomas / Meningiomas / Ependymomas / Medulloblastomas / ATRT / Brain metastases / Diffuse Intrinsic Pontine Glioma (DIPG)
Mouse Models and Genomics
Mouse models/ Genomics / Proteogenomics / Large datasets
Metabolism
Metabolic reprogramming / RNA biology / Lipid biology
Microenvironment, Angiogenesis and Immunology
Angiogenesis / Engineered T cell vs checkpoint inhibition / Monocytes
Drug Development and Preclinical Studies
Drug design / Drug screening / Preclinical modeling / Blood brain barrier
Therapeutics and Clinical Trials
Trial design / Heterogeneity
Reviews
There are no reviews yet.